Institute of Infectiology, Center for Molecular Biology of Inflammation, University of MünsterMünster, Germany.
Institute of Experimental Pathology, Center for Molecular Biology of Inflammation, University of MünsterMünster, Germany.
Front Cell Infect Microbiol. 2017 Apr 13;7:119. doi: 10.3389/fcimb.2017.00119. eCollection 2017.
Effector proteins secreted by the type 3 secretion system (T3SS) of pathogenic bacteria have been shown to precisely modulate important signaling cascades of the host for the benefit of the pathogens. Among others, the non-LEE encoded T3SS effector protein NleC of enteropathogenic (EPEC) is a Zn-dependent metalloprotease and suppresses innate immune responses by directly targeting the NF-κB signaling pathway. Many pathogenic bacteria release potent bacterial toxins of the A-B type, which-in contrast to the direct cytoplasmic injection of T3SS effector proteins-are released first into the environment. In this study, we found that NleC displays characteristics of bacterial A-B toxins, when applied to eukaryotic cells as a recombinant protein. Although lacking a B subunit, that typically mediates the uptake of toxins, recombinant NleC (rNleC) induces endocytosis via lipid rafts and follows the endosomal-lysosomal pathway. The conformation of rNleC is altered by low pH to facilitate its escape from acidified endosomes. This is reminiscent of the homologous A-B toxin AIP56 of the fish pathogen (). The recombinant protease NleC is functional inside eukaryotic cells and cleaves p65 of the NF-κB pathway. Here, we describe the endocytic uptake mechanism of rNleC, characterize its intracellular trafficking and demonstrate that its specific activity of cleaving p65 requires activation of host cells e.g., by IL1β. Further, we propose an evolutionary link between some T3SS effector proteins and bacterial toxins from apparently unrelated bacteria. In summary, these properties might suggest rNleC as an interesting candidate for future applications as a potential therapeutic against immune disorders.
III 型分泌系统(T3SS)分泌的效应蛋白已被证实可精确调节宿主的重要信号级联反应,从而使病原体受益。在其他效应蛋白中,肠致病性大肠杆菌(EPEC)的非李氏编码 T3SS 效应蛋白 NleC 是一种 Zn 依赖性金属蛋白酶,通过直接靶向 NF-κB 信号通路来抑制先天免疫反应。许多致病性细菌释放具有 A-B 型特征的强效细菌毒素,与 T3SS 效应蛋白的直接细胞质注射不同,这些毒素首先被释放到环境中。在这项研究中,我们发现当作为重组蛋白应用于真核细胞时,NleC 表现出细菌 A-B 毒素的特征。尽管缺乏通常介导毒素摄取的 B 亚基,但重组 NleC(rNleC)通过脂筏诱导内吞作用,并遵循内体溶酶体途径。rNleC 的构象通过低 pH 值发生改变,以促进其从酸化的内体中逃逸。这让人联想到鱼类病原体()的同源 A-B 毒素 AIP56。重组蛋白酶 rNleC 在真核细胞内具有功能,并可切割 NF-κB 途径的 p65。在这里,我们描述了 rNleC 的内吞摄取机制,表征了其细胞内运输,并证明其切割 p65 的特定活性需要宿主细胞的激活,例如通过 IL1β。此外,我们提出了一些 T3SS 效应蛋白和来自明显无关细菌的细菌毒素之间的进化联系。总之,这些特性可能表明 rNleC 作为一种有前途的治疗免疫紊乱的潜在治疗候选物具有吸引力。